Logical versus absolute lymphocyte count–guided preemptive therapy for cytomegalovirus prevention in kidney transplant recipients: a randomized controlled trial

ALC-guided monitoring could demonstrate effectiveness comparable to that of routine CMV DNA surveillance for CMV infection prevention in KT recipients. Given its simplicity and availability, ALC may serve as a feasible and cost-efficient adjunct for guiding preemptive therapy in low- to moderate-risk solid organ transplant recipients.